scispace - formally typeset
D

Deepak Reyon

Researcher at Harvard University

Publications -  53
Citations -  17227

Deepak Reyon is an academic researcher from Harvard University. The author has contributed to research in topics: Genome editing & Transcription activator-like effector nuclease. The author has an hindex of 33, co-authored 51 publications receiving 15306 citations. Previous affiliations of Deepak Reyon include Iowa State University & University of Minnesota.

Papers
More filters
Journal ArticleDOI

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.

TL;DR: It is found that single and double mismatches are tolerated to varying degrees depending on their position along the guide RNA (gRNA)-DNA interface, and off-target cleavage of CRISPR-associated (Cas)9-based RGNs is characterized.
Journal ArticleDOI

Efficient genome editing in zebrafish using a CRISPR-Cas system

TL;DR: It is shown that the CRISPR-Cas system functions in vivo to induce targeted genetic modifications in zebrafish embryos with efficiencies similar to those obtained using zinc finger nucleases and transcription activator-like effector nucleases.
Journal ArticleDOI

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

TL;DR: It is reported that truncated gRNAs, with shorter regions of target complementarity <20 nucleotides in length, can decrease undesired mutagenesis at some off-target sites by 5,000-fold or more without sacrificing on-target genome editing efficiencies.
Journal ArticleDOI

FLASH assembly of TALENs for high-throughput genome editing

TL;DR: The fast ligation-based automatable solid-phase high-throughput (FLASH) system is described, a rapid and cost-effective method for large-scale assembly of TALENs and it is demonstrated that FLASH facilitates high- throughput genome editing at a scale not currently possible with other genome modification technologies.
Journal ArticleDOI

Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing

TL;DR: D dimeric RNA-guided FokI nucleases (RFNs) are described that can recognize extended sequences and edit endogenous genes with high efficiencies in human cells and are likely to be useful in applications that require highly precise genome editing.